Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia.

Hatano, Masakazu; Kamei, Hiroyuki; Kato, Azusa; Takeuchi, Ippei; Hanya, Manako; Uno, Junji; Yamada, Shigeki; Fujita, Kiyoshi; Iwata, Nakao

Hatano, Masakazu; Kamei, Hiroyuki; Kato, Azusa; Takeuchi, Ippei; Hanya, Manako; Uno, Junji; Yamada, Shigeki; Fujita, Kiyoshi; Iwata, Nakao.

Afiliación

Hatano M; Department of Psychiatry, Fujita Health University School of Medicine, Nagoya, Japan.
Kamei H; Department of Clinical Pharmacy, Fujita Health University School of Medicine, Nagoya, Japan.
Kato A; Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Takeuchi I; Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Hanya M; Department of Clinical Pharmacy, Fujita Health University School of Medicine, Nagoya, Japan.
Uno J; Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Yamada S; Department of Psychiatry, Okehazama Hospital, Toyoake, Japan.
Fujita K; Office of Clinical Pharmacy Practice and Health Care Management, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Iwata N; Department of Psychiatry, Okehazama Hospital, Toyoake, Japan.

Clin Psychopharmacol Neurosci ; 15(2): 132-137, 2017 May 31.

Article en En | MEDLINE | ID: mdl-28449560

Palabras clave

Adverse drug events; Antipsychotic agents; Schizophrenia; Surveys and questionnaires

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Psychopharmacol Neurosci Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación:

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google